Frankenfish one step closer to market
FDA quietly moves forward during the Christmas season
Due to an overwhelming number of comments, the FDA has extended to comment period on genetically modified salmon.
According to Andrew Kimbrell, founder of The Center For Food Safety: “In all my years of organizing for sensible food policy in Washington, DC, this is the first time I have ever seen the FDA extend a comment period. This shows that the FDA is feeling the political pressure, and hopefully rethinking what looks like it would be a disastrous policy.”
During the Christmas 2012 holiday, the FDA quietly moved the genetically modified salmon called “frankenfish” one step closer to market.
The Food and Drug Administration released draft documents that assessed the environmental risks posed by AquAdvantage salmon, which grow faster than regular Atlantic salmon.
The agency found, on a preliminary basis, that the GM fish, produced by AquaBounty Technologies of Massachusetts, posed no significant threat.
Mutated by scientists to grow twice as fast as a normal salmon, the genetically modified salmon created by the company AquAdvantage was blocked for approval by Congress back in 2011 due to health and environmental concerns.
The fact of the matter is that numerous heads of the FDA have a deep (or even current) history with biotech giants like Monsanto. People like Michael R. Taylor, the current Deputy Commissioner for Foods at the FDA, was a Vice President at Monsanto. This is the same man that led an assault and subsequent shutdown of the largest organic peanut butter factory. Meanwhile, tumor-linked GMOs roam free.
And so will this genetically modified salmon unless activism prevails against the FDA and AquaAdvantage.
Click here to support: The Real Food Channel
The Brasscheck/Real Food Reading List
We recommend these books as a foundation for educating yourself about health in the 21st Century.